Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes

Inclusion Criteria

• •1. The research group consists of T1DM patients who first used oral hypoglycemic drugs from January 2013 to June 2024 and had a glycated hemoglobin level of \>= 7%; The control group consisted of T1DM patients who maintained only insulin treatment regimen and had glycated hemoglobin \>= 7%;
• •2. Age \>= 18 years old;
• •3. At least one recorded HbA1c value before the start of treatment;
• •4. Maintain medication regimen as needed from baseline to at least 3 months;
• •5. Record the first glycated hemoglobin value after treatment.